EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.13.11.6 | Olivopontocerebellar Atrophies |
1825460 |
Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. |
causal interaction diagnostic usage unassigned |
3 4 0 |
1.13.11.6 | Carcinoma, Hepatocellular |
7514594 |
Molecular cloning and functional expression of human 3-hydroxyanthranilic-acid dioxygenase. |
ongoing research unassigned |
4 0 |
1.13.11.6 | Glioma |
23548271 |
The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress. |
ongoing research unassigned |
2 0 |
1.13.11.6 | Huntington Disease |
2967497 |
3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims. |
causal interaction diagnostic usage unassigned |
1 2 0 |
1.13.11.6 | Hyperglycemia |
25454523 |
Changes in mouse liver and chicken embryo yolk sac membrane soluble proteins due to an organophosphorous insecticide (OPI) diazinon linked to several noncholinergic OPI effects in mice and chicken embryos. |
unassigned |
0 |
1.13.11.6 | Infections |
28402179 |
Antiviral Effect of IDO in Mouse Fibroblast Cells During Influenza Virus Infection. |
unassigned |
0 |
1.13.11.6 | Lymphoma, B-Cell |
34272611 |
Novel urine biomarkers to distinguish UTI from culture-negative pyuria. |
diagnostic usage ongoing research unassigned |
3 3 0 |
1.13.11.6 | Neurodegenerative Diseases |
24274468 |
2-Aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step toward new antiexcitotoxic agents. |
causal interaction therapeutic application unassigned |
4 1 0 |
1.13.11.6 | Seizures |
7805640 |
Differential expression of the astrocytic enzymes 3-hydroxyanthranilic acid oxygenase, kynurenine aminotransferase and glutamine synthetase in seizure-prone and non-epileptic mice. |
diagnostic usage ongoing research therapeutic application unassigned |
3 2 1 0 |
1.13.11.6 | Seizures |
11026503 |
Anticonvulsant effects of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631. |
ongoing research unassigned |
4 0 |